No new Omicron case in Gujarat for 2nd day; tally unchanged at 264

Ahmedabad city has so far reported the highest number of Omicron cases

testing
Representative image
Press Trust of India Ahmedabad
1 min read Last Updated : Jan 12 2022 | 9:39 PM IST

Gujarat did not report any new case of the Omicron variant of COVID-19 for the second day in a row on Wednesday, keeping its tally unchanged at 264, the state health department said.

At the same time, 13 more patients infected with the highly contagious strain were discharged, it said. With this, a total of 238 Omicron patients have been discharged so far, leaving only 26 such cases under treatment, said the department said in a release. Out of 13 new recoveries, nine were from Vadodara and four from Anand districts, said the release.

Ahmedabad city has so far reported the highest number of 110 Omicron cases, out of which 102 have recovered. Vadodara has reported 44 cases and 41 recoveries, Anand 27 cases and as many recoveries, and Surat 20 cases and as many recoveries, it said. The active Omicron cases are currently in nine districts of Gujarat - Ahmedabad, Vadodara, Gandhinagar, Bhavnagar, Bharuch, Banaskantha, Rajkot, Amreli and Jamnagar, as per the release.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jan 12 2022 | 9:39 PM IST

Next Story